A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of the Zolpidem Tartrate Sublingual Lozenge in Adult Subjects With Insomnia Characterized by Difficulty Returning to Sleep After Awakening in the Middle-of-the-Night (MOTN).
Latest Information Update: 23 Aug 2013
At a glance
- Drugs Zolpidem (Primary)
- Indications Sleep maintenance insomnia
- Focus Registrational; Therapeutic Use
- 19 Nov 2010 Results presented at the 10th International Forum on Mood and Anxiety Disorders.
- 16 Jun 2009 Actual initiation date (May 2007), actual end date (Nov 2007) and actual number of patients (295) added as reported by ClinicalTrials.gov.
- 09 Jun 2009 Results presented at the 23rd Annual Meeting of the Associated Professional Sleep Societies in Seattle, Washington USA, accoridng to Transcept Pharmeuticals media release.